Laddar...
Monocyte-to-macrophage switch reversibly impaired by Ibrutinib
Ibrutinib is increasingly adopted for treating lymphoid malignancies. While growing amounts of data pile up about Ibrutinib mechanism of action on neoplastic B cells, little is known about its impact on other immune cells. Here we investigated the effect of Ibrutinib on monocyte/macrophage functions...
Sparad:
| I publikationen: | Oncotarget |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Impact Journals LLC
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6443008/ https://ncbi.nlm.nih.gov/pubmed/30956776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26744 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|